Your browser doesn't support javascript.
Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs.
Kociolek, Larry K; Muller, William J; Yee, Rebecca; Dien Bard, Jennifer; Brown, Cameron A; Revell, Paula A; Wardell, Hanna; Savage, Timothy J; Jung, Sarah; Dominguez, Samuel; Parikh, Bijal A; Jerris, Robert C; Kehl, Sue C; Campigotto, Aaron; Bender, Jeffrey M; Zheng, Xiaotian; Muscat, Emily; Linam, Matthew; Abuogi, Lisa; Smith, Christiana; Graff, Kelly; Hernandez-Leyva, Ariel; Williams, David; Pollock, Nira R.
  • Kociolek LK; Division of Infectious Diseases, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Muller WJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Yee R; Division of Infectious Diseases, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Dien Bard J; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Brown CA; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Revell PA; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Wardell H; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Savage TJ; Texas Children's Hospital, Houston, Texas, USA.
  • Jung S; Baylor College of Medicine, Houston, Texas, USA.
  • Dominguez S; Texas Children's Hospital, Houston, Texas, USA.
  • Parikh BA; Baylor College of Medicine, Houston, Texas, USA.
  • Jerris RC; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Kehl SC; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Campigotto A; Department of Pathology and Laboratory Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Bender JM; Department of Pathology and Laboratory Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Zheng X; Department of Pediatrics, Division of Infectious Diseases, University of Colorado, Aurora, Colorado, USA.
  • Muscat E; Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Linam M; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Abuogi L; Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Smith C; Department of Pathology, Children's Wisconsin, Milwaukee, Wisconsin, USA.
  • Graff K; Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Hernandez-Leyva A; Department of Paediatric Laboratory Medicine, Hospital for Sick Kids, Toronto, Canada.
  • Williams D; Division of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Pollock NR; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
J Clin Microbiol ; 59(1)2020 12 17.
Article in English | MEDLINE | ID: covidwho-1048659
ABSTRACT
The distribution of upper respiratory viral loads (VL) in asymptomatic children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unknown. We assessed PCR cycle threshold (Ct) values and estimated VL in infected asymptomatic children diagnosed in nine pediatric hospital testing programs. Records for asymptomatic and symptomatic patients with positive clinical SARS-CoV-2 tests were reviewed. Ct values were (i) adjusted by centering each value around the institutional median Ct value from symptomatic children tested with that assay and (ii) converted to estimated VL (numbers of copies per milliliter) using internal or manufacturer data. Adjusted Ct values and estimated VL for asymptomatic versus symptomatic children (118 asymptomatic versus 197 symptomatic children aged 0 to 4 years, 79 asymptomatic versus 97 symptomatic children aged 5 to 9 years, 69 asymptomatic versus 75 symptomatic children aged 10 to 13 years, 73 asymptomatic versus 109 symptomatic children aged 14 to 17 years) were compared. The median adjusted Ct value for asymptomatic children was 10.3 cycles higher than for symptomatic children (P < 0.0001), and VL were 3 to 4 logs lower than for symptomatic children (P < 0.0001); differences were consistent (P < 0.0001) across all four age brackets. These differences were consistent across all institutions and by sex, ethnicity, and race. Asymptomatic children with diabetes (odds ratio [OR], 6.5; P = 0.01), a recent contact (OR, 2.3; P = 0.02), and testing for surveillance (OR, 2.7; P = 0.005) had higher estimated risks of having a Ct value in the lowest quartile than children without, while an immunocompromised status had no effect. Children with asymptomatic SARS-CoV-2 infection had lower levels of virus in their nasopharynx/oropharynx than symptomatic children, but the timing of infection relative to diagnosis likely impacted levels in asymptomatic children. Caution is recommended when choosing diagnostic tests for screening of asymptomatic children.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Load / Asymptomatic Infections / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Infant, Newborn Language: English Year: 2020 Document Type: Article Affiliation country: Jcm.02593-20

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Load / Asymptomatic Infections / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Infant, Newborn Language: English Year: 2020 Document Type: Article Affiliation country: Jcm.02593-20